Normand Anne N, Cannon Christopher P, Lewis Valerae O, Lin Patrick P, Yasko Alan W
Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Clin Orthop Relat Res. 2007 Jun;459:146-9. doi: 10.1097/BLO.0b013e3180619554.
Intralesional excision of intraosseous grade 1 periacetabular chondrosarcoma may seem an attractive alternative to the current recommendation of joint-sacrificing, en bloc resection. We report eight patients who initially underwent this treatment to identify if local tumor control can be achieved consistently. All patients had a percutaneous biopsy that was interpreted as grade 1 chondrosarcoma. The final histology after curettage indicated Grade 1 chondrosarcoma in five patients, Grade 2 in two, and dedifferentiated chondrosarcoma in one. Three of the five patients with true grade 1 chondrosarcoma have been free of disease at a median followup of 108 months. The other two patients with grade 1 chondrosarcoma on the curettage specimen recurred as higher-grade tumors. Three patients died of high-grade chondrosarcoma at a median of 23 months (range 17-72 months). Overall, the majority of patients in this cohort had either a misdiagnosis or recurrence of higher-grade disease. Based on these observations, in the absence of a predictable method to identify the true intraosseous grade 1 chondrosarcomas of the pelvis, curettage must be undertaken with the understanding that a percutaneous biopsy may misrepresent the histologic grade and that curettage may result in a higher risk of recurrence.
对于髋臼周围1级骨内软骨肉瘤,瘤内切除似乎是一种有吸引力的替代方案,可替代目前推荐的牺牲关节的整块切除。我们报告了8例最初接受这种治疗的患者,以确定是否能始终如一地实现局部肿瘤控制。所有患者均接受了经皮活检,结果均被诊断为1级软骨肉瘤。刮除术后的最终组织学检查显示,5例为1级软骨肉瘤,2例为2级,1例为去分化软骨肉瘤。5例真正的1级软骨肉瘤患者中,3例在中位随访108个月时无疾病复发。刮除标本显示为1级软骨肉瘤的另外2例患者复发为高级别肿瘤。3例患者死于高级别软骨肉瘤,中位时间为23个月(范围17 - 72个月)。总体而言,该队列中的大多数患者要么被误诊,要么出现高级别疾病复发。基于这些观察结果,在缺乏可预测方法来识别骨盆真正的骨内1级软骨肉瘤的情况下,进行刮除术时必须明白,经皮活检可能无法准确反映组织学分级,且刮除术可能导致更高的复发风险。